US 11,969,442 B1
الصحة - Health
2024
مكتب البراءات الأمريكي - US Patent Office
Ahmed; Hany Mohamed Abd El-Lateef (Al-Ahsa, SA), Shabaan; Saadeldin Elsayed Ibrahim (Al-Ahsa, SA), Alessa; Jihad Wadai Saleh (Al-Ahsa, SA)
Covid-19 binding aerosols are provided. The Covid-19 binding aerosols include Fe.sub.3O.sub.4 microparticles, at least one organoselenium compound, at least one essential oil, and incense. The Covid-19 binding aerosols may be formulated for use in any product that is capable of emitting aerosols, including but not limited to as air fresheners, as incense, or the like. The Fe.sub.3O.sub.4 microparticles may have an average size of 5,000 nm-10,000 nm (between 5-10 μm). The Covid-19 binding aerosols are formulated as aerosol compositions having an average size of greater than 60 μm-100 μm to ensure effective binding to virions.